Ricerca Biosciences, LLC is pleased to announce the addition of Sylvain Mandeville, Ph.D., as director of bioanalytical services. Dr. Mandeville will be based in Concord, Ohio, with responsibility for all bioanalytical services.
Dr. Mandeville´s background includes extensive management experience with bioanalytical services, including over fifteen years of varied experience in the contract research industry. He also possesses several years of experience as a research scientist and was responsible for the ideation, development, evaluation, and implementation of new bioanalytical methods required for maintaining and expanding activities of the Analytical Research Center (ARC).
Prior to joining Ricerca, Dr. Mandeville led bioanalytical and business development efforts for LAB Research Ltd. As the senior director, one of Dr. Mandeville´s responsibilities was to reengineer the analytical department and set up a bioanalytical department while supervising the operations of the bioanalytical services as wells as promoting the sales and marketing activities. Dr. Mandeville also managed bioanalytical services for Phoenix International Life Sciences in Montreal, Canada.
"We are extremely pleased to have someone with Sylvain´s knowledge and abilities join our team," said Dr. James Szabo, Vice President "“ Biology Services. "He has demonstrated excellence in operating contract bioanalytical services in the domestic and international marketplace. Dr. Mandeville´s contributions will complement Ricerca´s successes in building a unique preclinical services team based in Concord, Ohio."
ABOUT RICERCA
Ricerca is the only North American CRO that takes pharmaceutical and biotech companies straight through from IP to IND. Our state–of–the–art facility combined with over 300 scientists and support staff provides all of the discovery and development services required to bring target or drug candidates to complete IND submission. Ricerca´s unique ability to seamlessly integrate chemistry and biology, along with report writing and regulatory services at one location, allows companies to achieve their preclinical destination"”faster and without any detours.
